Liver and pulmonary metastases of the colorectal carcinoma – the experience of the Department of Surgery, University Hospital in Pilsen
Authors:
V. Třeška; J. Vodička; V. Špidlen; T. Skalický; J. Fichtl; V. Šimánek; J. Šafránek; A. Sutnar; J. Brůha
Authors‘ workplace:
Chirurgická klinika FN a LFUK v Plzni, přednosta: Prof. MUDr. V. Třeška, DrSc.
Published in:
Rozhl. Chir., 2013, roč. 92, č. 9, s. 488-493.
Category:
Original articles
Overview
Introduction:
Liver and pulmonary metastases of the colorectal carcinoma develop in about 20–70%, resp. in 10–22% patients with the colorectal carcinoma. Their treatment is still a matter of discussion. The aim of our study was to evaluate the results of surgical treatment as a part of the multimodal approach.
Material and methods:
30 patients with liver and pulmonary colorectal metastases were operated on between 2002 and 4/2013. The average age was 62.8 ± 10.7 years. 19 patients had metachronous and 11 synchronous metastases. The liver metastases preceded pulmonary in 14 cases, and vice versa in 5 patients. Both types of metastases developed in seven patients simultaneously. Liver resection was performed in 23, radiofrequency ablation (RFA) in 7 patients. Laser pulmonary metastasectomy was performed in 15, pulmonary resection in 14 and RFA in one patient. The liver procedure preceded pulmonary in 25 patients. 73.3% patients had adjuvant oncological treatment.
Results:
30 days mortality rate was 3.3% (N=1) for the actinomycotic sepsis complicated with MRSA infection. Morbidity rate was 10%. Recurrence of liver metastases developed in 6 patients. RFA was performed in all patients. The median of overall and disease free survival was 6.9, resp. 1.1 years.
Conclusion:
Surgical treatment as a part of the multimodal treatment is the only radical treatment for patients with liver and pulmonary metastases. It offers good long-term results.
Key words:
liver and pulmonary metastases of the colorectal carcinoma – surgical treatment
Sources
1. Marín C, Robles R, Conesa AL, Torres J, Flores DP, et al. Outcome patient selection for surgical treatment of hepatic and pulmonary metastases from colorectal cancer. Dis Colon Rectum 2013;56:43–50.
2. Carpizo DR, Are Ch, Jarnagin W, DeMatteo R, Fong Y, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol 2009;16:2138–2146.
3. Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J gastrointest Surg 2011;3: 183–189.
4. Cai GX, Cai SJ. Multi-modality treatment of colorectal liver metastases.World J Gastroenterol 2012; 18:16–24.
5. Yedibela S, Klein P, Feuchter K. Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol 2006;13: 1538–1544.
6. Shah SA, Haddad R, Al-Sukhni W. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am coll Surg 2006;202: 468–475.
7. Skalický T, Třeška V, Špidlen V, Vodička V, Sutnar A, et al. Chirurgická léčba jaterních a plicních metastáz kolorektálního karcinomu. Rozhl Chir 2010;89:253–255.
8. Takahashi S, Nagai K, Saito N. Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma. Jpn J Clin Oncol 2007;37:186–192.
9. Barlow AD, Nakas A, Pattenden C. Surgical treatment of combined hepatic and pulmonary colorectal cancer metastases. Eur J Surg Oncol 2009;35: 307–312.
10. Schule S, Dittmar Y, Knosel T. Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis 2012;80:231–243.
11. Třeška V, Skalický T, Sutnar A, Liška V. Chirurgická léčba jaterních metastáz kolorektálního karcinomu. Rozhl Chir 2009; 88:69–75.
12. Vodička J, Špidlen V, Šimánek V, Šafránek J, Skalický T, et al. Surgical therapy of pulmonary metastases – 10-year results. Bratisl Lek Listy 2013;114:218–24.
13. Meimarakis G, Angele M, Conrad C, Schauer R, Weidenhagen R, et al. Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone. Langenbecks Arch Surg 2013;398:265–276.
14. Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 2003;197:386–391.
15. Headrick JR, Miller DL, Nagorney DM. Surgical treatment of hepatic and pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2001;71:975–979.
16. Miller G, Biernacki P, Kemeny NE. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 2007;205:231–238.
17. Murata S, Moriya Y, Akasu T. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 1998;83:1086–1093.
18. Adam R, Avisar E, Ariche A. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347–353.
19. Koch M, Weitz J, Kienle P. Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg 2001;136:85–89.
20. Kopetz S, Chang GJ, Overman MJ. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009; 27:3677–3683.
21. Villeneuve PJ, Sundaresan RS. Surgical management of colorectal lung metastasis. Clin Colon Rectal Surg 2009;22:233–241.
22. Hattori N, Kanemitsu Y, Komori K, Shimizu Y, Sano T, et al. Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs. World J Surg. 2013; 37:1315–1321.
23. Meimarakis G, Angele M, Conrad C, Schauer R, Weidenhagen R, et al. Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone. Langenbecks Arch Surg 2013;398:265–276.
24. Shimada H, Tanaka K, Endou I. Treatment for colorectal liver metastases: a review. Lengenbeks Arch Surg 2009;394:973–983.
25. Fakih M. Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach? Expert Rev Anticancer Ther 2008;8:1471–1480.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2013 Issue 9
Most read in this issue
- Smoking and postoperative complications
- Recurrent subareolar non puerperal abscess of breast with fistules of lactiferous ducts (Zuskas disease)
- Rare complication after stapled hemorrhoidectomy
- Liver and pulmonary metastases of the colorectal carcinoma – the experience of the Department of Surgery, University Hospital in Pilsen